哈佛醫(yī)學(xué)院波士頓兒童醫(yī)院2020年博士后職位招聘（神經(jīng)科學(xué)、分子生物學(xué)方向）
A postdoctoral position is available in the Ozcan Laboratory (www.ozcanlab.com) in the Division of Endocrinology, Boston Children’s Hospital, Harvard Medical School.
The position is offered to study the role of endoplasmic reticulum (ER) stress signaling in hypothalamic control of metabolic homeostasis, neuron activity and leptin resistance in obesity. The interested candidates can check our recent publications in this area to understand the area of research better:
· Ozcan L, et al. Cell Metabolism. 2009 Jan 7;9(1):35-51. Endoplasmic reticulum stress plays a central role in development of leptin resistance.
· Liu J et al., Cell. 2015 May 21;161(5):999-1011. Treatment of obesity with celastrol.
· Lee J et al., Nature Medicine. 2016 Sep;22(9):1023-32. Withaferin A is a leptin sensitizer with strong antidiabetic properties in mice.
· Feng X, et al., Nature Medicine.2019 March 4-Online publication. IL1R1 is required for celastrol’s leptin-sensitization and antiobesity effects.
The ideal candidate for this position should have a Ph.D., M.D. or M.D./Ph.D. degrees with strong experience in neuroscience and molecular biology evident by peer-reviewed publications in reputable journals. Candidates, who have expertise in electrophysiological recordings of neurons, stereotaxic surgeries and molecular biology with experience in obesity-related metabolic research will be given priority.
Interested candidates should forward their research interests, curriculum vitae along with the name and contact information of three referees to Dr. Umut Ozcan; e-mail: umut.ozcan@childrens.harvard.edu
為防止簡(jiǎn)歷投遞丟失請(qǐng)抄送一份至：boshijob@126.com（郵件標(biāo)題格式：應(yīng)聘職位名稱+姓名+學(xué)歷+專業(yè)+中國(guó)博士人才網(wǎng)）
中國(guó)-博士人才網(wǎng)發(fā)布
聲明提示：凡本網(wǎng)注明“來源：XXX”的文/圖等稿件，本網(wǎng)轉(zhuǎn)載出于傳遞更多信息及方便產(chǎn)業(yè)探討之目的，并不意味著本站贊同其觀點(diǎn)或證實(shí)其內(nèi)容的真實(shí)性，文章內(nèi)容僅供參考。
